信息搜索
信息关键字：药
  

共有5246条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]

·金城医药获电子烟专卖许可决定书2022-6-14 9:51:09
·6月14日投资避雷针：这家药企三大“独家”品种被踢出地方医保2022-6-14 9:12:58
·皮海洲：弃购是打新的“后悔药” 理性看待投资者的弃购行为2022-6-14 8:56:21
·“药茅”大跌！买入PK卖出龙虎榜上演机构激战2022-6-14 7:02:16
·公告精选：金城医药获电子烟专卖许可决定书；勤上股份筹划控制权变更2022-6-13 21:52:49
·A股资金面日报：主力资金减持医药股等龙虎榜机构抢筹药明康德等2022-6-13 20:50:23
·21CC肿瘤情报（第10期）：百济神州PD1获批第9项适应症；全球首个靶向Trop2的ADC药物在中国获批2022-6-13 20:12:12
·步长制药：控股子公司产品退出省级医保目录2022-6-13 16:52:01
·医药生物行业周报：2021年度药品审评报告发布关注创新药产业链投资机会2022-6-13 15:43:38
·信邦制药净利润增长57.25%“医疗服务+”平台运营模式推动三主业齐头并进2022-6-13 15:35:46
·巨丰投顾：美股重挫“药茅”跌停高位十字星下A股是否该防守？2022-6-13 15:26:40
·突发！CXO板块大跌，药明康德开盘跌停；双语直播带货火了，新东方在线股价一度暴涨100%2022-6-13 14:27:20
·翰宇药业：HY3000完成对OmicronBA.2变异株体外活病毒抑制试验2022-6-13 13:36:39
·突发！“同花顺崩了”上热搜工行系统疑似崩溃华为云紧急回应！3000亿“药茅”突然跌停20万股东扎心2022-6-13 12:58:44
·突发！CXO板块大跌药明康德开盘跌停双语直播带货火了新东方在线股价一度暴涨100%2022-6-13 12:54:21
·海普瑞：肝素全球龙头短期利差扩大，长期积极拓宽大分子CDMO+创新药领域2022-6-13 11:13:33
·英国最新通报：猴痘经性网络扩散病毒基因突变或增强耐药性-财经2022-6-12 9:48:05
·新能源太火这家药企宣布进军锂电！网友：啥时候收购宁德比亚迪？2022-6-12 7:57:05
·定增投向锂电+新冠药！三倍医药牛股抗新冠原料药关键中间体欲扩产2022-6-11 21:00:03
·药企疯狂“囤猴”背后：实验猴单价超16万元不到四年涨超10倍2022-6-11 9:39:14

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]